Weifang Huibo Pharmaceutical Technology Co., Ltd. is engaged in R & D and synthesis customization of API and pharmaceutical intermediates. There are more than 1000 square pilot plant, more than 5-100l laboratory reaction devices and more than 1000-3000l pilot plant. The main reaction categories are: chlorination, bromination, nitration, oxidation, reduction (carbonyl, nitro), methylation; The main research directions are: chiral resolution of epoxy compounds and synthesis of chiral intermediates, pyridine derivatives, boric acid and its derivatives.